JMP Securities Cuts Prime Medicine (NYSE:PRME) Price Target to $6.00
Prime Medicine (NYSE:PRME – Free Report) had its price target trimmed by JMP Securities from $10.00 to $6.00 in a research report released on Tuesday morning,Benzinga reports. The firm currently has a market outperform rating on the stock. PRME has been the topic of a number of other reports. Wall Street Zen raised Prime Medicine […]
Prime Medicine (NYSE:PRME – Free Report) had its price target trimmed by JMP Securities from $10.00 to $6.00 in a research report released on Tuesday morning,Benzinga reports. The firm currently has a market outperform rating on the stock. PRME has been the topic of a number of other reports. Wall Street Zen raised Prime Medicine […]
